http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-3254-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c5e77c181522ee1fd44df1ae5ac2196 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2006-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc50e087fee79b84a390ace58735ac40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f160f36da58bff698aa587976b26fe |
| publicationDate | 2018-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JO-3254-B1 |
| titleOfInvention | Dipeptidase peptidase inhibitors to treat diabetes |
| abstract | The present invention relates to pharmaceutical compositions comprising 2-] 6- (3-amino-piperidine-1-yl) -3-methyl-2, 4-dimoxy-3-4-dihydro (2H)-pyrimidine -1-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-6-3-Amino-piperidin-1-yl - ylmethyl] -4-fluoro benzonitrile and salts are pharmaceutically acceptable. |
| priorityDate | 2005-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420894078 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11360300 |
Total number of triples: 16.